Phytohealth Corp Asset Resilience Ratio
Phytohealth Corp asset resilience ratio. Phytohealth Corp (4108) has an Asset Resilience Ratio of 38.05% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Phytohealth Corp to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Phytohealth Corp (2002–2025)
Asset resilience ratio of Phytohealth Corp from 2002 to 2025. This chart shows how Phytohealth Corp's Asset Resilience Ratio has changed over time. Read 4108 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Phytohealth Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Phytohealth Corp asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$917.71 Million | 38.05% |
| Total Liquid Assets | NT$917.71 Million | 38.05% |
Asset Resilience Insights
- Very High Liquidity: Phytohealth Corp maintains exceptional liquid asset reserves at 38.05% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Phytohealth Corp Industry Peers by Asset Resilience Ratio
Compare Phytohealth Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Phytohealth Corp Asset Resilience Ratio by Year (2002–2025)
Phytohealth Corp asset resilience ratio by year from 2002 to 2025. The table below shows the annual Asset Resilience Ratio data for Phytohealth Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 41.81% | NT$983.93 Million ≈ $31.00 Million |
NT$2.35 Billion ≈ $74.13 Million |
-1.53pp |
| 2024-12-31 | 43.35% | NT$1.06 Billion ≈ $33.32 Million |
NT$2.44 Billion ≈ $76.86 Million |
-7.85pp |
| 2023-12-31 | 51.19% | NT$1.20 Billion ≈ $37.91 Million |
NT$2.35 Billion ≈ $74.05 Million |
-2.10pp |
| 2022-12-31 | 53.30% | NT$1.26 Billion ≈ $39.71 Million |
NT$2.36 Billion ≈ $74.50 Million |
-0.17pp |
| 2021-12-31 | 53.47% | NT$1.32 Billion ≈ $41.61 Million |
NT$2.47 Billion ≈ $77.82 Million |
+14.86pp |
| 2020-12-31 | 38.61% | NT$698.66 Million ≈ $22.01 Million |
NT$1.81 Billion ≈ $57.01 Million |
+4.35pp |
| 2019-12-31 | 34.25% | NT$644.66 Million ≈ $20.31 Million |
NT$1.88 Billion ≈ $59.29 Million |
+33.38pp |
| 2018-12-31 | 0.87% | NT$18.02 Million ≈ $567.70K |
NT$2.07 Billion ≈ $65.16 Million |
-47.48pp |
| 2017-12-31 | 48.35% | NT$1.06 Billion ≈ $33.39 Million |
NT$2.19 Billion ≈ $69.07 Million |
+4.22pp |
| 2016-12-31 | 44.13% | NT$1.07 Billion ≈ $33.72 Million |
NT$2.42 Billion ≈ $76.40 Million |
+26.22pp |
| 2015-12-31 | 17.91% | NT$419.00 Million ≈ $13.20 Million |
NT$2.34 Billion ≈ $73.72 Million |
-30.75pp |
| 2014-12-31 | 48.65% | NT$1.21 Billion ≈ $38.15 Million |
NT$2.49 Billion ≈ $78.42 Million |
-1.00pp |
| 2013-12-31 | 49.65% | NT$1.40 Billion ≈ $44.18 Million |
NT$2.82 Billion ≈ $88.97 Million |
+47.31pp |
| 2012-12-31 | 2.35% | NT$67.69 Million ≈ $2.13 Million |
NT$2.88 Billion ≈ $90.84 Million |
-11.98pp |
| 2011-12-31 | 14.33% | NT$236.51 Million ≈ $7.45 Million |
NT$1.65 Billion ≈ $52.00 Million |
-18.82pp |
| 2010-12-31 | 33.15% | NT$632.06 Million ≈ $19.91 Million |
NT$1.91 Billion ≈ $60.08 Million |
-11.99pp |
| 2009-12-31 | 45.14% | NT$954.21 Million ≈ $30.06 Million |
NT$2.11 Billion ≈ $66.60 Million |
+27.80pp |
| 2008-12-31 | 17.34% | NT$186.78 Million ≈ $5.88 Million |
NT$1.08 Billion ≈ $33.94 Million |
-13.55pp |
| 2007-12-31 | 30.89% | NT$480.49 Million ≈ $15.14 Million |
NT$1.56 Billion ≈ $49.01 Million |
+4.53pp |
| 2004-12-31 | 26.36% | NT$80.45 Million ≈ $2.53 Million |
NT$305.18 Million ≈ $9.61 Million |
-25.81pp |
| 2003-12-31 | 52.17% | NT$179.52 Million ≈ $5.66 Million |
NT$344.09 Million ≈ $10.84 Million |
+48.13pp |
| 2002-12-31 | 4.04% | NT$6.30 Million ≈ $198.48K |
NT$156.02 Million ≈ $4.92 Million |
-- |
About Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more